Artwork
iconShare
 
Manage episode 510307082 series 3684506
Content provided by Ran Chen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ran Chen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
This episode of MedTech Global Insights offers a deep dive into Singapore's medical device market, revealing why it's the premier strategic hub for companies looking to expand into Asia. We break down the Health Sciences Authority (HSA) regulatory framework and explain its risk-based classification system. We go beyond the basics to uncover how your company can leverage existing approvals, such as a CE Mark or FDA clearance, to access expedited registration pathways. Discover how a successful Singaporean market entry can serve as a powerful launchpad for penetrating the entire, rapidly growing ASEAN region. Consider this scenario: A European MedTech company with a novel Class C device wants to enter the Asian market but fears a long, complex, and country-by-country registration process. They are facing the pain point of duplicating efforts and losing valuable time. This episode details how, by targeting Singapore first and utilizing their existing CE certification, they could potentially slash their approval timeline from over a year to just a few months, turning a daunting challenge into a strategic victory. Key Takeaways: 1. Why is Singapore considered the top strategic gateway for MedTech companies entering Asia? 2. What are the four device classes under Singapore's HSA, and how do they directly impact your registration timeline and costs? 3. How can your existing FDA clearance or EU CE mark dramatically accelerate your approval process in Singapore? 4. What is the mandatory role of a Local Authorized Representative, and why is it far more than just a name on a form? 5. How can a successful Singapore registration act as a "regulatory passport" to other promising ASEAN markets? 6. What are the critical post-market surveillance and vigilance responsibilities you cannot afford to ignore after approval? 7. How can advanced data tools and AI streamline the creation of the ASEAN CSDT technical dossier for a faster submission? To learn more about crafting your Asia-Pacific market access strategy, contact us at [email protected] or visit https://pureglobal.com/.
  continue reading

56 episodes